| Name |
|---|
Revenue Change |
Gross Change |
EBITDA Change |
EBIT Change |
Earnings Change |
eFFECTOR Therapeutics Inc is a clinical-stage biopharmaceutical company focused on pioneering the development of a new class of oncology drugs referred to as selective translation regulator inhibitors (STRIs).
Benzinga Rankings give you vital metrics on any stock – anytime.
You can purchase shares of EFFECTOR THERAPUTCS INC by eFFECTOR Therapeutics, Inc. (OTCEM:EFTR) through any online brokerage.
There are no as such competitors for EFFECTOR THERAPUTCS INC by eFFECTOR Therapeutics, Inc..
EFFECTOR THERAPUTCS INC by eFFECTOR Therapeutics, Inc. has a consensus price target of $24.00.
The stock price for EFFECTOR THERAPUTCS INC by eFFECTOR Therapeutics, Inc. (OTCEM: EFTR) is $0.0002 last updated October 6, 2026 at 2:43 PM EDT.
There are no upcoming dividends for EFFECTOR THERAPUTCS INC by eFFECTOR Therapeutics, Inc..
EFFECTOR THERAPUTCS INC by eFFECTOR Therapeutics, Inc. does not have any upcoming earnings scheduled.
There is no upcoming split for EFFECTOR THERAPUTCS INC by eFFECTOR Therapeutics, Inc..
EFFECTOR THERAPUTCS INC by eFFECTOR Therapeutics, Inc. is in the Health Care sector and Biotechnology industry. They are listed on the OTCEM.
